Thursday, March 30

[CS01] Collaborative Session 01: Innovative diagnostic technologies

Date & Time	March 30 (Thursday), 9:00-10:15	Room 1
Chairs	Jin-Yeong Han (Dong-A University College of Medicine, Korea) In-Suk Kim (Pusan National University School of Medicine, Korea)
Presentations	Accelerate breakthroughs in hematology with single cell sequencing Geoffrey McDermott (10x Genomics, Inc., USA) AI technology in the field of blood disease Tabe Yoko (Juntendo University, Japan) Discover the unique power of using droplet digital PCR (ddPCR) for hematology-oncology applications Gina Sun (Bio-Rad Laboratories, USA)) Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference YongKeun Park (Tomocube Inc., Korea)

[SS01] Scientific Session 01: Challenging issues in childhood blood disorders

Date & Time	March 30 (Thursday), 9:00-10:15	Room 2
Chairs	Hoon Kook (Chonnam National University Medical School, Korea) Nack-Gyun Chung (The Catholic University of Korea, Korea)
Presentations	How to diagnosis and treat neutropenia in childhood Kelly Walkovich (University of Michigan, USA) Updates in the treatment of pediatric relapsed/refractory acute myeloid leukemia Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea) Use of chimeric antigen receptor (CAR) expressing T cells for acute lymphoblastic leukemia (ALL) Micheal Verneris (Children’s Hospital Colorado, USA)

[SS02] Scientific Session 02: How far has cell therapy developed in Hodgkin lymphoma?

Date & Time	March 30 (Thursday), 9:00-10:15	Room 3
Chairs	Hyeon-Seok Eom (National Cancer Center, Korea) Sung-yong Oh (Dong-A University College of Medicine, Korea)
Presentations	Pathogenesis of hodgkin lymphoma Ralf Küppers (University of Duisburg-Essen, Germany) Emerging cellular therapy in HL Natalie S Grover (The University of North Carolina at Chapel Hill, USA) Novel treatment of relapsed/refractory hodgkin lymphoma Hyeon-Seok Eom (National Cancer Center, Korea)

[ES01] Education Session 01: Different treatment goals for overcoming resistance or functional cure in CML

Date & Time	March 30 (Thursday), 9:00-10:15	Room 4
Chairs	Chul Won Jung (Sungkyunkwan University School of Medicine, Korea) Hawk Kim (Gachon University College of Medicine, Korea)
Presentations	Asciminib: the first-in-class allosteric inhibitor of BCR/ABL1 kinase Eun-Ji Choi (University of Ulsan College of Medicine, Korea) Treatment after failure of frontline therapy of CML-CP including allo-HSCT Jieun Uhm (Hanyang University College of Medicine, Korea) Update on treatment free remission Jae Joon Han (Kyung Hee University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Date & Time	March 30 (Thursday), 10:30-11:15	Room 1
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation	Regulation of iron metabolism Martina U. Muckenthaler (University of Heidelberg, Germany)

[PS01] Presidential Symposium

Date & Time	March 30 (Thursday), 11:15-12:00	Room 1
Chairs	Seongsoo Jang (University of Ulsan College of Medicine, Korea)
Presentation	What can Nano do for Medicine? Taeghwan Hyeon (Seoul National University, Korea)

[SY01] Satellite Symposium 01 (Sponsored by Novartis)

Date & Time	March 30 (Thursday), 12:15-13:05	Room 1
Chair	Dong-Wook Kim (Eulji University School of Medicine, Korea)
Presentation	ASCIMINIB, new paradigm treatment option in CML for patients who were previously treated with 2 or more TKIs Andreas Hocchaus (Jena University Hospital, Germany)

[SY02] Satellite Symposium 02 (Sponsored by Roche)

Date & Time	March 30 (Thursday), 12:15-13:05	Room 2
Chair	Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	Unmet need in 1L DLBCL and POLARIX trial Georg Lenz (University Hospital in Münster, Germany)

[SY03] Satellite Symposium 03 (Sponsored by BMS-Celgene)

Date & Time	March 30 (Thursday), 12:15-13:05	Room 3
Chair	Ho Sup Lee (Kosin University College of Medicine, Korea)
Presentation	Maintenance treatment post autotransplant for multiple myeloma Kevin Song (Vancouver General Hospital, Canada)

[JS01] Asian Hematology Session I (JSM & KMMWP) - Multiple Myeloma

Date & Time	March 30 (Thursday), 15:05-16:20	Room 1
Chairs	Kihyun Kim (Sungkyunkwan University School of Medicine, Korea) Chiaki Nakaseko (International University of Health and Welfare School of Medicine, Japan)
Presentations	POEMS syndrome: advances in molecular pathophysiology and treatment Chiaki Nakaseko (International University of Health and Welfare School of Medicine, Japan) Updates on POEMS syndrome in Korea Jin Seok Kim (Yonsei University College of Medicine, Korea) Therapeutic approach of Waldenström's macroglobulinemia in Japan Hiroshi Handa (Gunma University, Japan) Clinical researches on Waldenström's macroglobulinemia in Korea Hosup Lee (Kosin University College of Medicine, Korea)

[SS03] Scientific Session 03: Where we are, in the era of new agents for aplastic anemia?

Date & Time	March 30 (Thursday), 15:05-16:20	Room 2
Chairs	Jae Wook Lee (The Catholic University of Korea, Korea) Ho Joon Im (University of Ulsan College of Medicine, Korea)
Presentations	Aplastic anemia: Current management considerations Emma M. Groarke (National Institutes of Health, USA) Clinical and molecular factors of clonal evolution in aplastic anemia Jaroslaw P. Maciejewski (Cleveland Clinic, USA) Non-transplant therapy for pediatric aplastic anemia Jae Wook Lee (The Catholic University of Korea, Korea)

[SS04] Scientific Session 04: How can we approach thrombocytopenia?

Date & Time	March 30 (Thursday), 15:05-16:20	Room 3
Chairs	Soo-Mee Bang (Seoul National University College of Medicine, Korea) Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
Presentations	Diagnosis and treatment of TA-TMA; Current challenge and future strategies Sandro Rossetti (Hospital Alexion Pharmaceuticals, Inc., USA) Genetics of inherited thrombocytopenia Kathleen Freson (University of Leuven, Belgium) Advances on pathogenesis and diagnosis of TTP Hyun Kyung Kim (Seoul National University College of Medicine, Korea)

[ES02] Education Session 02: How I treat rare lymphomas?

Date & Time	March 30 (Thursday), 15:05-16:20	Room 4
Chairs	Hyo Jung Kim (Hallym University College of Medicine, Korea) Dok Hyun Yoon (Asan Medical Center, University of Ulsan College of Medicine, Korea)
Presentations	Intravascular B-cell lymphoma Youngwoo Jeon (The Catholic University of Korea, Korea) T-large granular lymphocytic leukemia Jae-Cheol Jo (University of Ulsan College of Medicine, Korea) Lymphomatoid granulomatosis Jeong-Ok Lee (Seoul National University Bundang Hospital, Korea)

[CS02] Collaborative Session 02: Innovative therapeutic technologies

Date & Time	March 30 (Thursday), 16:35-17:50	Room 1
Chairs	Keon Hee Yoo (Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea) Yong Park (Korea University school of medicine, Korea)
Presentations	A Phase 1a Study of BR101801, PI3Kγδ and DNA PK Triple Inhibitor, in Adult Patients with Advanced Hematologic Malignancies Bong-Seog Kim (Boryung Co. Ltd., Korea) The gut microbiome as a novel predictive biomarker and therapeutic target in lymphoma patients Woorim Kang (CJ Bioscience Inc., Korea) Bispecific antibody : ABL Bio Jonghwa Won (ABL Bio Inc., Korea) TKI development in CML Sung-Min Ahn (ImmunoForge Inc., Korea)

[SS05] Scientific Session 05: Artificial intelligence application in hematology

Date & Time	March 30 (Thursday), 16:35-17:50	Room 2
Chairs	Mina Hur (Konkuk University School of Medicine, Korea) Myung-Hyun Nam (Korea University school of medicine, Korea)
Presentations	Artificial intelligence in hematology: basic concepts Roni Shouval (Memorial Sloan Kettering Cancer Center, USA) How ML deepens our understanding of hematologic malignancies? Valeria Visconte (Cleveland Clinic, USA) Pitfalls of AI for medical application Jongmun Choi (Green Cross Genome, Korea)

[SS06] Defining and improving survival of high-risk multiple myeloma

Date & Time	March 30 (Thursday), 16:35-17:50	Room 3
Chairs	Chang-Ki Min (The Catholic University of Korea, Korea) Jin Seok Kim (Yonsei University College of Medicine, Korea)
Presentations	Identification of high-risk multiple myeloma Niels van de Donk (Amsterdam University Medical Center, The Netherlands) Updated diagnosis and treatment of plasma cell leukemia Sung-Hoon Jung (Chonnam National University Hwasun Hospital , Korea) Safety and efficacy of locally produced novel BCMA CART cells for relapsed/refractory multiple myeloma and al amyloidosis Moshe Gatt (The Hebrew University of Jerusalem, Israel)

[ES03] Education Session 03: Rare hematologic malignancies with cutaneous manifestation

Date & Time	March 30 (Thursday), 16:35-17:50	Room 4
Chairs	Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) Ahn Jae-Sook (Chonnam National University Hwasun Hospital, Korea)
Presentations	Sezary syndrome and mycosis fungoides Hyewon Lee (National Cancer Center, Korea) Systemic mastocytosis Hyun Jung Lee (Kyung Hee University College of Medicine, Korea) Plasmacytoid dendritic cell neoplasm Yoo Jin Lee (University of Ulsan College of Medicine, Korea)

Friday, March 31

[JS02] ASH-KSH Joint Symposium - T Cell Lymphoma

Date & Time	March 31 (Friday), 9:00-10:15	Room 1
Chairs	Seong soo Jang (University of Ulsan College of Medicine, Korea) Robert Brodsky (John Hopkins University, USA)
Presentations	NK cells: next generation cell therapies for cancer Katy Rezvani (The University of Texas MD Anderson Cancer Center, USA) Treatment of extranodal NK/T-cell lymphoma: Korean Lymphoma Working Party experience Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) CART for the treatment of T cell malignancies John DiPersio (Washington University School of Medicine, USA) Treatment of peripheral T-cell lymphoma: Korean Lymphoma Working Party experience Deok-Hwan Yang (Chonnam National University Medical School, Korea)

[SS07] Scientific Session 07: What is the direction of the new CAR-T therapy?

Date & Time	March 31 (Friday), 9:00-10:15	Room 2
Chairs	Seok-Goo Cho (The Catholic University of Korea, Korea) Je-Jung Lee (Chonnam National University Medical School, Korea)
Presentations	Engineering next-generation T cells for cancer immunotherapy Yvonne Chen (University of California, USA) Development of CAR-T therapy for acute lymphoblastic leukemia Hyoung Jin Kang (Seoul National University College of Medicine, Korea) Updates on the latest developments in CAR-T therapies Hiroshi Fujiwara (Mie University, Japan)

[SS08] Scientific Session 08: Comprehensive approaches to understand hemophilia

Date & Time	March 31 (Friday), 9:00-10:15	Room 3
Chairs	Eun Jin Choi (Daegu Catholic University Hospital, Korea) Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
Presentations	Genotyping of hemophilia, why we need it and how we do? Jill Johnsen (University of Washington, USA) Value of national cohort registry data of hemophilia Jung Woo Han (Yonsei University College of Medicine, Korea) Essentials of laboratory issues in Emicizumab Sang Hyuk Park (Ulsan University Hospital, Korea)

[ES04] Education Session 04: Back to the basic: transfusion support

Date & Time	March 31 (Friday), 9:00-10:15	Room 4
Chairs	Jong Ho Won (Soonchunhyang University College of Medicine, Korea) Ji Hyang LIM (The Catholic University of Korea, Korea)
Presentations	Transfusion support for HSCT Dong Wook Jekarl (The Catholic University of Korea, Korea) Evidence based transfusion threshold Dae-Hyun Ko (University of Ulsan College of Medicine, Korea) Current status of manufactured blood cells Eun Jung Baek (Hanyang University College of Medicine, Korea)

[PL02] Plenary Lecture 02

Date & Time	March 31 (Friday), 10:30-11:15	Room 1
Chair	Chul-Ju Yoo (Yonsei University College of Medicine, Korea)
Presentation	The role of the intestinal microbiome in cancer immunotherapy Marcel van den Brink (Memorial Sloan Kettering Cancer Center, USA)

[SY04] Satellite Symposium 04 (Sponsored by Kyowa Kirin)

Date & Time	March 31 (Friday), 12:15-13:05	Room 1
Chairs	Jong Wook Lee (Seoul St. Mary's Hospital, The Catholic University of Korea, Korea)
Presentation	Recent advances in the pathogenesis and treatment of aplastic anemia Kohei Hosokawa (Kanazawa University, Japan)

[SY05] Satellite Symposium 05 (Sponsored by Handok)

Date & Time	March 31 (Friday), 12:15-13:05	Room 2
Chair	Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Presentation	Value of intensive therapy in high-risk AML Martin Bornhaeuser (University Hospital Carl Gustav Carus Dresden, Germany)

[SY06] Satellite Symposium 06 (Sponsored by Janssen)

Date & Time	March 31 (Friday), 12:15-13:05	Room 3
Chair	Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	When and whom to start treatment of CLL patients and how to optimally manage CLL patients with Imbruvica Paolo Ghia (IRCCS Ospedale San Raffaele, Italy)

[JS03] EHA-KSH Joint Symposium - Myelodysplastic Syndrome

Date & Time	March 31 (Friday), 15:05-16:20	Room 1
Chairs	June-Won Cheong (Yonsei University College of Medicine, Korea) Lionel Adès (Hospital Saint Louis and Paris University, France)
Presentations	Novel approaches in MDS Uwe Platzbecker (Leipzig University Hospital, Germany) Treatment of MDS: Korean AML/MDS working party experience June-Won Cheong (Yonsei University College of Medicine, Korea) Standard management of MDS Lionel Adès (Hospital Saint Louis and Paris University, France) Genetic alterations in myelodysplastic neoplasms Yoo-Jin Kim (The Catholic University of Korea, Korea)

[SS09] Scientific Session 09: Which immune therapy is our future weapon against AML?

Date & Time	March 31 (Friday), 15:05-16:20	Room 2
Chairs	Hyeoung-Joon Kim (Chonnam National University Medical School, Korea) Hee-Je Kim (The Catholic University of Korea, Korea)
Presentations	Immune checkpoint inhibition for AML ; CD47 blockade and beyond Naval Daver (MD Anderson Cancer Center, USA) Determining the barriers to successful CAR T cell therapy for AML Miriam Y Kim (University of Washington, USA) Adoptive T cell transfer of three universal tumor associated antigens-specific T cells for the treatment of AML Byung Sik Cho (The Catholic University of Korea, Korea)

[SS10] Scientific Session 10: Next-generation molecular genomic and cytogenomic technology in hematology

Date & Time	March 31 (Friday), 15:05-16:20	Room 3
Chairs	Myungshin Kim (The Catholic University of Korea, Korea) Yoon Hwan Chang (Seoul National University Hospital, Korea)
Presentations	A transcriptomic approach to clinical diagnosis, prognosis and therapy selection in AML Aly Karsan (University of British Columbia, Canada) Whole genome sequencing of fluorescence in situ hybridized cells in hematologic malignancies using SLACS Sunghoon Kwon (Seoul National University, Korea) Next generation cytogenetics – optical mapping for comprehensive structural variant detection in hematological malignancies and beyond Alexander Hoischen ((Radboud University Medical Center, The Netherlands))

[ES05] Education Session 05: Practical issue in CAR-T

Date & Time	March 31 (Friday), 15:05-16:20	Room 4
Chairs	Jae-Yong Kwak (Jeonbuk National University Hospital, Korea) Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Presentations	Setting up the facility for CAR T cell therapy Ja Min Byun (Seoul National University College of Medicine, Korea) Technical aspect of manufacturing CAR T cell product Jong-Seo Lee (AbClon Inc., Korea) Managing adverse events of CAR T cell therapy Jae Won Yoo (The Catholic University of Korea, Korea)

[JS04] International Collaborative Session - Aplastic Anemia

Date & Time	March 31 (Friday), 16:35-17:50	Room 1
Chairs	Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea) Lalita Norasetthada (Chiang Mai University, Thailand)
Presentations	Overview of AA diagnosis and treatment in NIHBT, VietNam Nguyen Thi Thao (National Institute of Hematology and Blood Transfusion, Vietnam) The incidence and real-world outcome of aplastic anemia in Thailand Lalita Norasetthada (Chiang Mai University, Thailand) Role of TPO receptor agonists in aplastic anemia treatment Jun Ho Jang (Samsung Medical Center, Korea)

[SS11] Scientific Session 11: Liquid biopsy application in hematology

Date & Time	March 31 (Friday), 16:35-17:50	Room 2
Chairs	Myung Geun Shin (Chonnam National University Medical School, Korea) Seung-Tae Lee (Yonsei University College of Medicine, Korea)
Presentations	Cell-free DNA profiling for monitoring of complications of hematopoietic cell transplantation Iwijn De Vlaminck (Cornell University, USA) Microbial cell-free DNA sequencing to predict bloodstream infection in pediatric cancer patients Charles Gawad (Stanford University, USA) Clinical applications of circulating tumor DNA analysis in lymphoma Seung-Tae Lee (Yonsei University College of Medicine, Korea)

[SS12] Scientific Session 12: Up-to-date diagnostic and treatment strategies of adult ALL patients

Date & Time	March 31 (Friday), 16:35-17:50	Room 3
Chairs	Ho-Jin Shin (Pusan National University Hospital, Korea) Seok Lee (The Catholic University of Korea, Korea)
Presentations	Are we moving towards a chemo- and transplant-free management of Ph-positive adult ALL? Robin Foa (Sapienza University of Rome, Italy) Development of more-effective CAR T-cell therapy for ALL Saar I Gill (University of Pennsylvania, USA) Overcoming high-risk features in adult ALL patients Jae-Ho Yoon (The Catholic University of Korea, Korea)

Saturday, April 1

[JS05] Asian Hematology Session II - Red Blood Cell Disorder

Date & Time	April 1 (Saturday), 9:00-10:15	Room 1
Chairs	Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea) Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
Presentations	Overview of thalassaemia and hemoglobinopathies in Bangladesh Mahmood A. Chowdhury (Chattogram Maa-O-Shishu Hospital Medical College, Bangladesh) Current situation of thalassemia care in Cambodia Chean Sophal (National Pediatric Hospital, Cambodia) Epidemiology and diagnosis of hemolytic anemia in Korea Heewon Chueh (Dong-A University College of Medicine, Korea)

[SS13] Scientific Session 13: Current knowledge of human hematopoietic stem cell

Date & Time	April 1 (Saturday), 9:00-10:15	Room 2
Chairs	Deog-Yeon Jo (Chungnam National University College of Medicine, Korea) Byung-Soo Kim (Korea University College of Medicine, Korea)
Presentations	Single cell HSPC map William J. Greenleaf (Stanford University, USA) Humanized mouse and non-human primate: Animal models for hematopoietic stem cell research Kyung-Rok Yu (Seoul National University, Korea) What we know about HSC homing? Xinxin Huang (Fudan University, China)

[SS14] Scientific Session 14: What's new in chronic lymphocytic leukemia?

Date & Time	April 1 (Saturday), 9:00-10:15	Room 3
Chairs	Young Rok Do (Keimyung University School of Medicine, Korea) TBD
Presentations	Translating scientific advances in CLL Richard Rosenquist (Karolinska Institute, Sweden) Patient selection for time limited versus continued therapy Jennifer R. Brown (Dana-Farber Cancer Institute, USA) MRD monitoring in CLL Patients Ki-Seong Eom (The Catholic University of Korea, Korea)

[ES06] Education Session 06: Novel therapeutics for myeloproliferative neoplasms

Date & Time	April 1 (Saturday), 9:00-10:15	Room 4
Chairs	Sung-Yong Kim (Konkuk University School of Medicine, Korea) Chul Won Choi (Korea University Guro Hospital, Korea)
Presentations	Prognostication in MPNs (including mutation abnormalities) Junshik Hong (Seoul National University Hospital, Korea) Novel Therapeutics for MF (including cyotpenic myelofibrosis) Sung-Eun Lee (The Catholic University of Korea, Korea) Novel Therapeutics for ET/PV Seugyun Yoon (Soonchunhyang University Seoul Hospital, Korea)

[PL03] Plenary Lecture 03

Date & Time	April 1 (Saturday), 10:30-11:15	Room 1
Chairs	Kyung Ha Ryu (Ewha Womans University, Korea)
Presentation	Recent advance in the hematopoietic stem cell research Toshio Suda (National University of Singapore, Singapore)